Investing
The company will use the funds to support a 510(k) submission to the FDA for its Flexi-Port SLF-TANL for oncology patients.
The company plans to offer an aggregate of 7.9 million shares of its common stock with an initial public offering price between $18 and $20 per share.
The company's computer vision technology tracks supply and implant usage in hospital operating and procedural rooms.
Indian e-clinic startup CureBay also looks to expand its rural network.
The funds will be used to help the company expand into the employer and health plan markets and speed up the development of its AI technology for providers and members.
AI-powered value-based behavioral health company Ontrak and generative AI radiology workflow company Rad AI also garnered investments.
The behavioral health-focused company will use the Series A funds to accelerate product development and expand support for its customer base.
The company offers an at-home test where a breath sample is collected and analyzed by trained dogs and AI to detect early-stage cancer.
The company uses AI and ML to assist biopharma companies with clinical trials and will use the funds to expand its precision medicine and clinical development tools.
Also, Lytus adds an AI-driven blood logistics platform to its health technology portfolio.